Douglas Elliman Inc

The asset remains in a Stage 4 decline with failed rallies at declining EMAs, confirming a bearish medium-term bias. Short-term price is neutral, trading sideways below sloping EMAs and lacking a clear bounce signal. Execution should be deferred and focused on trimming into rallies back into the 9 EMA and 21 EMA zone for rejection at resistance.

• ↑Q2 revenue grew 4.5% YoY to $283.4M while net loss shrank from $22.7M to $2.7M.
• ↑General & admin expenses fell 32% YoY, boosting margin recovery.
• ↓Stock trades at 37.9×P/E vs. industry’s 32.7×, signaling rich valuation.